A Phase 1, Open-Label Study to Evaluate the Effect of Food on the Single-Dose Pharmacokinetics and a Drug-Drug Interaction Evaluation of Itraconazole and Carbamazepine on INCB123667 When Administered Orally to Healthy Adult Participants

Inclusion Criteria: * Ability to comprehend and willingness to sign a written ICF for the study. * Age 19 (in compliance with Nebraska state law) to 55 years, inclusive, at the time of signing the ICF. * Body mass index between 18.0 and 32.0 kg/m2, inclusive, at screening. Note: Only up to 25% of the participants may be enrolled with a BMI \> 30 to ≤ 32.0 kg/m2. * No clinically significant findings on screening evaluations (clinical, laboratory results \[with the exception of lipids\], and ECGs). * Ability to swallow and retain oral tablets. * Willingness to avoid pregnancy or fathering child…